Sinadjan, Rosita .

HRN: 12-34-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2026
CEFTRIAXONE 1G (VIAL)
05/04/2026
05/11/2026
IV
2g
OD
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: